Friction-Coefficient Test Consistency for Pharmaceutical Flexible Packaging Audit
Friction coefficient of pharmaceutical flexible packaging is often overlooked, yet it serves as a critical indicator affecting the stability of automated packaging lines and GMP audit compliance. In audits conducted by pharmaceutical manufacturers, pharmaceutical packaging suppliers and third-party testing laboratories, most inspectors focus heavily on barrier performance, heat seal strength and solvent residue. However, inconsistency in friction coefficient testing creates hidden compliance risks, potentially leading to invalid test reports, non-traceable data and difficulties in batch quality assessment during regulatory inspections and customer audits.
Abnormal friction coefficients of pharmaceutical flexible packaging will directly cause failures on automatic production lines. A high static friction coefficient increases film feeding resistance and results in film deviation and heat seal misalignment. If static friction is excessively low, slipping between film layers will trigger inaccurate bag lengths and material stacking faults. These defects not only cause production downtime and material waste, but may also bring packaging seal failures and compromise the long-term stability of enclosed medicines. More concealed risks originate inside laboratories. Poor repeatability of friction coefficient test results means inconsistent readings from repeated tests on the same batch of samples. Under such circumstances, batch stability of packaging materials cannot be objectively evaluated, and auditors may question the validity of incoming material acceptance and release testing, which leads to GMP non-conformities.
Multiple factors contribute to inconsistent friction coefficient data of pharmaceutical flexible packaging. Common issues include burrs or curled edges after sample cutting, insufficient conditioning of specimens under constant temperature and humidity, residual magnetism or dust contamination on sliders and test platforms, infrequent instrument calibration, and confusion between inclined-plane testing and horizontal traction methods. These two testing principles cannot generate interchangeable data. The inclined-plane method is designed for static friction coefficient measurement by capturing the critical tilt angle at which the slider starts sliding. The horizontal traction method can acquire both static and kinetic friction coefficients. Many laboratories have received audit observations for mistakenly applying inclined-plane test data to standards requiring both static and kinetic friction values, forming compliance loopholes.
For audit scenarios of pharmaceutical flexible packaging, these two instruments can form a complementary testing solution. GM‑F1 Inclined Plane Coefficient of Friction Tester adopts the inclined lifting principle and specializes in measuring static friction coefficient and critical tilt angle. Its test bench and sliders are processed by demagnetization and residual magnetism inspection to minimize systematic errors. It complies with ASTM D4918 and TAPPI T815 standards, and is suitable for rapid screening of pharmaceutical composite films and paperboard samples to evaluate opening performance and static sliding characteristics, acting as an efficient tool for R&D and preliminary incoming inspection. Note that the inclined-plane instrument only delivers static friction coefficient without kinetic friction data, so it cannot independently meet the complete testing requirements of GB/T10006 and ISO8295.
When tests require both static and kinetic friction coefficients for batch release, registration submission and full standard compliance verification, GM‑4 Coefficient of Friction Tester is the preferred option. Built in accordance with GB/T10006, ISO8295 and ASTM D1894, this horizontal traction tester supports fast force sensor calibration and optional heating module to simulate high-temperature service conditions. Its software generates full test curves for audit traceability, making it the primary instrument for comprehensive friction performance inspection of pharmaceutical packaging materials.
A common misunderstanding among laboratories is relying on a single tester for all inspections without fully understanding the application boundaries of each device. From an audit perspective, test methods must match the requirements defined in product specifications. If standards demand both static and kinetic friction coefficients, using only static friction data obtained from GM‑F1 will constitute method deviation. GM‑F1 may be adopted for rapid static friction screening, but test reports must clearly state the test method and instrument model; screening data cannot be used as formal release test results.
To maintain friction coefficient test consistency and mitigate audit risks, laboratories should implement standardized SOPs. First, standardize sample preparation: cut films free of burrs and condition samples under specified constant temperature and humidity. Second, maintain equipment properly: keep sliders and test platforms clean and calibrate force and angle sensors on schedule. Third, clarify instrument application scope: use GM‑F1 for rapid static friction screening and GM‑4 for formal release tests of static and kinetic friction, and mark instrument models and corresponding standards clearly on reports. Fourth, archive raw test curves to satisfy data traceability requirements for GMP audits.
For quality control of pharmaceutical flexible packaging, friction coefficient is not an isolated numerical value. It links raw material incoming inspection, production process optimization, finished product release and audit verification. Distinguishing between inclined-plane and horizontal traction principles, reasonably deploying GM‑F1 and GM‑4 friction testers, and separating screening tests from formal release inspections help enterprises avoid audit risks arising from improper method selection and poor data repeatability. Reliable friction coefficient testing safeguards the quality of pharmaceutical packaging.
